• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙对原发性甲状旁腺功能亢进患者血清中完整甲状旁腺激素水平的抑制作用。

Suppression by calcium of serum levels of intact parathyroid hormone in patients with primary hyperparathyroidism.

作者信息

Bergenfelz A, Valdermarsson S, Ahrén B

机构信息

Department of Surgery, Lund University, Sweden.

出版信息

Horm Res. 1993;39(3-4):146-51. doi: 10.1159/000182715.

DOI:10.1159/000182715
PMID:8262476
Abstract

Primary hyperparathyroidism (pHPT) is associated with a right-shifted relation between parathyroid hormone (PTH) secretion and calcium. However, it is also possible that a decreased suppressibility of PTH secretion by calcium is important for maintaining hypercalcemia in pHPT. We therefore compared the suppression of serum levels of intact PTH induced by a 1.5-gram oral calcium load in patients with mild pHPT with that in healthy subjects. The calcemic response to the oral calcium load was the same in the two groups and did not correlate with the degree of PTH suppression or to serum levels of vitamin D metabolites. It was found that serum levels of intact PTH were less suppressed by the oral calcium load in patients than in healthy subjects (p < 0.01), but with a considerable overlap between the two groups. The suppression of serum levels of intact PTH was correlated both to baseline serum total calcium levels (r = -0.55; p < 0.05) and osteocalcin levels (r = -0.69; p < 0.05) in the patients, but no such correlations were seen in the controls. We conclude that patients with pHPT have a decreased suppressibility of PTH secretion by calcium. Although this reduced suppressibility could be important for maintaining hypercalcemia in some patients with pHPT, it does not aid in the differential diagnosis between patients with mild pHPT and healthy subjects.

摘要

原发性甲状旁腺功能亢进症(pHPT)与甲状旁腺激素(PTH)分泌和钙之间的关系右移有关。然而,钙对PTH分泌的抑制性降低对于维持pHPT患者的高钙血症也可能很重要。因此,我们比较了轻度pHPT患者与健康受试者口服1.5克钙负荷后血清中完整PTH水平的抑制情况。两组对口服钙负荷的血钙反应相同,且与PTH抑制程度或维生素D代谢产物的血清水平无关。结果发现,与健康受试者相比,患者口服钙负荷后血清中完整PTH水平的抑制作用较小(p < 0.01),但两组之间有相当大的重叠。患者血清中完整PTH水平的抑制与基线血清总钙水平(r = -0.55;p < 0.05)和骨钙素水平(r = -0.69;p < 0.05)均相关,但在对照组中未观察到此类相关性。我们得出结论,pHPT患者钙对PTH分泌的抑制性降低。尽管这种降低的抑制性可能对某些pHPT患者维持高钙血症很重要,但它无助于轻度pHPT患者与健康受试者之间的鉴别诊断。

相似文献

1
Suppression by calcium of serum levels of intact parathyroid hormone in patients with primary hyperparathyroidism.钙对原发性甲状旁腺功能亢进患者血清中完整甲状旁腺激素水平的抑制作用。
Horm Res. 1993;39(3-4):146-51. doi: 10.1159/000182715.
2
Suppressibility of serum levels of PTH by calcium in the immediate postoperative period after surgery for primary hyperparathyroidism.
World J Surg. 1993 Nov-Dec;17(6):806-10. doi: 10.1007/BF01659104.
3
Effects of minor increase in serum calcium on the immunoheterogeneity of parathyroid hormone in healthy subjects and in patients with primary hyperparathyroidism.血清钙轻微升高对健康受试者和原发性甲状旁腺功能亢进患者甲状旁腺激素免疫异质性的影响。
Horm Res. 1995;43(6):294-9. doi: 10.1159/000184315.
4
Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects.正常血钙型原发性甲状旁腺功能亢进症、原发性甲状旁腺功能亢进症和健康受试者口服蛋白胨负荷和口服钙负荷对 PTH 的不同反应。
Eur J Endocrinol. 2012 Oct;167(4):491-7. doi: 10.1530/EJE-12-0362. Epub 2012 Aug 7.
5
Serum levels of thyrotropin are decreased by oral calcium in healthy subjects but not in patients with primary hyperparathyroidism.健康受试者口服钙后促甲状腺激素的血清水平会降低,但原发性甲状旁腺功能亢进患者不会。
Horm Res. 1994;42(6):273-7. doi: 10.1159/000184208.
6
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
7
Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism.
J Clin Endocrinol Metab. 1990 Apr;70(4):951-6. doi: 10.1210/jcem-70-4-951.
8
Immunoheterogeneity of parathyroid hormone pre- and postoperatively in primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者甲状旁腺激素术前及术后的免疫异质性
Langenbecks Arch Chir. 1995;380(2):119-24. doi: 10.1007/BF00186419.
9
Progressive escape from parathyroid suppression: a common phenomenon in primary hyperparathyroidism (a calcium clamp study).甲状旁腺抑制的进行性逃逸:原发性甲状旁腺功能亢进症中的常见现象(一项钙钳研究)
Clin Endocrinol (Oxf). 1994 Mar;40(3):309-15. doi: 10.1111/j.1365-2265.1994.tb03924.x.
10
Stimulation and suppression of intact parathyroid hormone (PTH1-84) in normal subjects and hyperparathyroid patients.正常受试者和甲状旁腺功能亢进患者体内完整甲状旁腺激素(PTH1-84)的刺激与抑制
Clin Endocrinol (Oxf). 1991 Jul;35(1):35-40. doi: 10.1111/j.1365-2265.1991.tb03493.x.

引用本文的文献

1
The relationship between postoperative parathormone suppression and surgical cure in primary hyperparathyroidism.原发性甲状旁腺功能亢进症术后甲状旁腺激素抑制与手术治愈之间的关系。
Front Endocrinol (Lausanne). 2025 Jul 30;16:1629719. doi: 10.3389/fendo.2025.1629719. eCollection 2025.
2
Immunoheterogeneity of parathyroid hormone pre- and postoperatively in primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者甲状旁腺激素术前及术后的免疫异质性
Langenbecks Arch Chir. 1995;380(2):119-24. doi: 10.1007/BF00186419.